Technology News and Research

RSS

Data on BioAlliance Pharma's oral chemotherapy nanoparticle formulation presented at the AAPS meeting

BioAlliance Pharma SA, a company dedicated to the treatment and supportive care of cancer and AIDS patients, has presented its results on new oral chemotherapy nanoparticle formulation at the AAPS (American Association of Pharmaceutical Scientists) Annual Meeting in Los Angeles (November 8 to 12, 2009).

13 Nov 2009

AvidBiotics granted U.S. and European patents concerning its DGR technology platform

AvidBiotics Corp. announced the issuance of foundational patents encompassing a completely novel mechanism for generating massive diversity within precisely targeted sites of protein-encoding DNA sequences. The technology platform is referred to as Diversity Generating Retroelements (DGR) and patents were issued in both the United States (#7,585,957) and in Europe (#1,173,995). UCLA and AvidBiotics Corp are co-assignees of the patents, and AvidBiotics holds exclusive, worldwide rights to the patents from UCLA.

13 Nov 2009

IVF Witness uses RFID to identify the sperm and eggs, and reduces the risk of lab errors in infertility treatment

A new software technology is helping to reduce the risk of laboratory errors in infertility treatment, by electronically identifying the sperm, eggs, resulting embryos and other materials used in in vitro fertilization (IVF) treatment cycles. Using non-invasive Radio Frequency Identification (RFID), IVF Witness(TM) can track a patient's sperm, eggs and embryos during the course of treatment. If the wrong material is introduced in the lab environment, IVF Witness alerts the staff, via visual and audible signals, to help prevent mislabeling of any materials.

12 Nov 2009

ClearCount Medical Solutions' SmartSponge System wins "Best of What's New" award

ClearCount Medical Solutions, an innovator of patient safety solutions for the operating room, announced today that the editors of Popular Science have named the SmartSponge® System one of the top technology innovations of 2009. As a winner off a “Best of What’s New” award in the health category, the SmartSponge System stands out as the first and only system to incorporate the efficiency of counting with the safety of detection for the prevention of left-behind sponges during surgery.

12 Nov 2009

Cequent Pharmaceuticals proposes the first test of an orally administered RNA interference drug in humans

Cequent Pharmaceuticals, a pioneer in the development of novel products to deliver RNAi-based treatments to prevent and treat human disease, has announced that it has filed its first IND (investigational new drug) application with the U.S. Food and Drug Administration (FDA).

12 Nov 2009

Second-quarter fiscal 2010 results announced by AdvanSource Biomaterials

AdvanSource Biomaterials Corporation, a leading developer of advanced polymer materials for a broad range of medical devices, today announced financial results for its fiscal 2010 second quarter ended September 30, 2009.

12 Nov 2009

New Cat B 750 FAST imaging agent launched by VisEn Medical

VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced today the commercial launch of its new Cat B 750 FAST(TM) imaging agent for measuring and monitoring cathepsin B activity associated with disease progression and therapeutic response in vivo. Cathepsin B expression is well known as a key biomarker and therapeutic target in a range of diseases, including atherosclerosis, oncology, and arthritis.

12 Nov 2009

Innovation of the Year: Littmann Electronic Stethoscope Model 3200 with Zargis Cardioscan software

3M Health Care and Zargis Medical, a majority-owned subsidiary of Speedus Corp. (Nasdaq:SPDE), announced today that the 3M™ Littmann® Electronic Stethoscope Model 3200 with Zargis Cardioscan™ software was named Popular Science’s “Innovation of the Year.” This prestigious honor, part of the publication’s annual “Best of What’s New Awards,” highlights outstanding innovation, vision and execution in technologic, scientific and medical advances for the year.

12 Nov 2009

American Medical Alert announces operating results for the third quarter of 2009

American Medical Alert Corp. a provider of healthcare communication services and advanced telehealth monitoring technologies, today announced operating results for the quarter and nine months ended September 30, 2009.

12 Nov 2009

Hyland Software's OnBase rated as one of the top DMI system solutions on the market

Your healthcare organization is in the market for a document management and imaging (DMI) system. There are dozens of vendors in the space, and each offers something at least slightly different than the others. It's a huge investment and there isn't room for error. Where do you begin your search for a standout vendor and product? Perhaps with a new report from KLAS titled, "Enterprise DMI: Finding the Right Stepping-Stone to Full EMR."

12 Nov 2009

Novadaq announces financial results for the third quarter of 2009

Novadaq® Technologies Inc., a developer of real-time imaging systems for use in the operating room, today announced 2009 third quarter revenues of $1,723,000 compared to revenue of $3,311,000 in third quarter 2008. In accordance with corporate policy, a previously reported order in excess of $2,000,000 has not been recorded in sales due to cash not yet received.

12 Nov 2009

Update on Alnylam Pharmaceuticals' RNAi pipeline, platform, and technology

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, is providing an update on its RNAi pipeline, platform, and technology at its R&D Day being held in New York today.

12 Nov 2009

Detailed review findings of EMPOWER study to evaluate the Maestro System released

EnteroMedics Inc., the developer of medical devices using neuroblocking technology to treat obesity and other gastrointestinal disorders, today announced preliminary findings from its ongoing detailed review of its EMPOWER™ study, a randomized, double-blind, controlled pivotal study designed to evaluate the safety and efficacy of the Maestro® System in the treatment of obesity.

12 Nov 2009

Meridian Bioscience announces fiscal 2009 fourth-quarter and full-year financial results

Net sales for the fourth quarter of fiscal 2009 were $42,461,000 as compared to $36,475,000 for the same period of the prior fiscal year, an increase of 16%. Net earnings for the fourth quarter of fiscal 2009 were $8,930,000, or $ 0.22 per diluted share, up 16% over the fourth quarter of fiscal 2008.

12 Nov 2009

Review of Mersana Therapeutics's lead compound, XMT-1001 to be published

Mersana Therapeutics, a platform-based cancer therapeutics company, announced today that a review of the Company's lead compound, XMT-1001, will appear in the November 12, 2009 special issue of Advanced Drug Delivery Reviews on Polymer Therapeutics: Clinical Applications and Challenges for Development.

12 Nov 2009

Bradmer Pharmaceuticals reports financial results for the third quarter of 2009

Bradmer Pharmaceuticals Inc. today announced its 2009 third quarter financial results.

12 Nov 2009

Financial results for the third quarter announced by A.D.A.M.

A.D.A.M., Inc., a leading provider of health information and benefit technology solutions, today announced its financial results for the third quarter ended September 30, 2009.

12 Nov 2009

D-Link to showcase its Green networking hardware at the HealthAchieve2009 conference

D-Link has been selected to showcase its environmentally responsible Green networking hardware as part of the Venture Green program in this year's HealthAchieve2009 conference and exhibition on Nov. 16-17 at the Metro Toronto Convention Centre.

12 Nov 2009

SHI offers services and investment options to financial institutions

Senior Housing Investments, LLC (SHI), a consortium of companies that have come together to assist financial institutions deal with troubled assets in the senior housing sector, announced today its services for lenders and investment bankers with current or planned investments in Assisted Living communities.

12 Nov 2009

Trubion Pharmaceuticals to present data on its TRU-016 product candidate at the ASH meeting

Trubion Pharmaceuticals, Inc. announced today the acceptance of two data presentations on its product candidate, TRU-016, at the 2009 American Society of Hematology (ASH) Annual Meeting Dec. 5-8, 2009 in New Orleans, Louisiana.

12 Nov 2009

Technology News and Research

Data on BioAlliance Pharma's oral chemotherapy nanoparticle formulation presented at the AAPS meeting

AvidBiotics granted U.S. and European patents concerning its DGR technology platform

IVF Witness uses RFID to identify the sperm and eggs, and reduces the risk of lab errors in infertility treatment

ClearCount Medical Solutions' SmartSponge System wins "Best of What's New" award

Cequent Pharmaceuticals proposes the first test of an orally administered RNA interference drug in humans

Second-quarter fiscal 2010 results announced by AdvanSource Biomaterials

New Cat B 750 FAST imaging agent launched by VisEn Medical

Innovation of the Year: Littmann Electronic Stethoscope Model 3200 with Zargis Cardioscan software

American Medical Alert announces operating results for the third quarter of 2009

Hyland Software's OnBase rated as one of the top DMI system solutions on the market

Novadaq announces financial results for the third quarter of 2009

Update on Alnylam Pharmaceuticals' RNAi pipeline, platform, and technology

Detailed review findings of EMPOWER study to evaluate the Maestro System released

Meridian Bioscience announces fiscal 2009 fourth-quarter and full-year financial results

Review of Mersana Therapeutics's lead compound, XMT-1001 to be published

Bradmer Pharmaceuticals reports financial results for the third quarter of 2009

Financial results for the third quarter announced by A.D.A.M.

D-Link to showcase its Green networking hardware at the HealthAchieve2009 conference

SHI offers services and investment options to financial institutions

Trubion Pharmaceuticals to present data on its TRU-016 product candidate at the ASH meeting

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News